Hunan Fangsheng Pharmaceutical Co., Ltd. Class ASSE: 603998

"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 6th Extraordinary Meeting of the 6th Board of Directors in 2026

Sep 30, 2026 · Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 30, 2026

Announcement on Resolutions of the 6th Extraordinary Meeting of the 6th Board of Directors in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Hunan Fangsheng Pharmaceutical Co., Ltd. Class A

"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Progress of Transfer of Certain Equity Interests in a Controlled Subsidiary and Introduction of Strategic InvestorsSep 23
"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 7
"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Outline of the 2026 Semi-annual Performance and Cash Dividend BriefingSep 1
"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Election of Employee Directors and Adjustment of the Remuneration and Appraisal Committee MembersAug 29

All Hunan Fangsheng Pharmaceutical Co., Ltd. Class A news releases